Mountain Valley MD Holdings (FRA:20MP) Interest Expense : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mountain Valley MD Holdings's interest expense for the three months ended in Dec. 2023 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mountain Valley MD Holdings's Operating Income for the three months ended in Dec. 2023 was € -0.67 Mil. Mountain Valley MD Holdings's Interest Expense for the three months ended in Dec. 2023 was € 0.00 Mil. Mountain Valley MD Holdings has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Mountain Valley MD Holdings Interest Expense Historical Data

The historical data trend for Mountain Valley MD Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings Interest Expense Chart

Mountain Valley MD Holdings Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Interest Expense

-0.01

Mountain Valley MD Holdings Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial														-	-	-	-	-

Mountain Valley MD Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Mountain Valley MD Holdings (FRA:20MP) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mountain Valley MD Holdings's Interest Expense for the three months ended in Dec. 2023 was €0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was €-0.67 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was €0.00 Mil.

Mountain Valley MD Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Mountain Valley MD Holdings had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Mountain Valley MD Holdings Inc has enough cash to cover all of its debt. Its financial situation is stable.

Mountain Valley MD Holdings (FRA:20MP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MVMDF:USA MVMD:Canada

Address

260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4

Website

https://www.mountainvalleymd.com

Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings (FRA:20MP) Headlines

No Headlines